Contraindications to magnetic resonance imaging

Magnetic resonance imaging (MRI) is a method that has evolved continuously during the past 20 years, yielding MR systems with stronger static magnetic fields, faster and stronger gradient magnetic fields, and more powerful radiofrequency transmission coils. It is increasingly being used and requested as several new indications have been established during the last few years—for example, cardiovascular MRI. To evaluate the contraindications to MRI is equivalent to understanding the safety issues surrounding the use MRI. MRI is often described as a “safe” modality due to the fact that, unlike x ray based systems, ionising radiation is not involved. However, there are hazards intrinsic to the MR environment that must be acknowledged and excluded. Most reported cases of MR related injuries and the few fatalities that have occurred have apparently been the result of failure to follow safety guidelines or have resulted from the use of inappropriate or outdated information related to the safety aspects of biomedical implants and devices. Therefore, for information on specific guidelines and devices, detailed sources of safety information—for example, dedicated websites (box 1)—are recommended.1 2 w1 w2 Risks associated with MRI may be attributed to one or to a combination of the three main mechanisms of the system: 1. Strong static magnetic fields —As a result of ferromagnetic interactions, an object or device may be moved, rotated, dislodged, or accelerated toward the magnet. The “projectile effect” means that, depending on the type of magnet and the intensity of the generated field, to varying extent, objects are attracted to the centre of the magnet (for example, helium or oxygen cylinders, ventilators, wheelchair, etc), possibly causing severe injuries and damage. Furthermore, articles such as metallic splinters, vascular clips, and cochlear implants may be dislodged. The strong magnetic field may also affect device function, as most, but importantly not …

[1]  A. Oto,et al.  Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. , 2008, AJR. American journal of roentgenology.

[2]  D. Bluemke,et al.  Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention , 2007, Circulation.

[3]  M. Dewey,et al.  Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patients , 2007, Journal of magnetic resonance imaging : JMRI.

[4]  A. Stecco,et al.  Patient safety issues in magnetic resonance imaging: state of the art , 2007, La radiologia medica.

[5]  John Gosbee,et al.  ACR guidance document for safe MR practices: 2007. , 2007, AJR. American journal of roentgenology.

[6]  G. Bongartz,et al.  Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? , 2007, Magnetic Resonance Materials in Physics, Biology and Medicine.

[7]  O. Faris,et al.  Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. , 2006, Circulation.

[8]  Samuel Valencerina,et al.  Septal repair implants: evaluation of magnetic resonance imaging safety at 3 T. , 2005, Magnetic resonance imaging.

[9]  S. Neubauer,et al.  Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. , 2005, The American journal of cardiology.

[10]  J. Fisher MRI: Safety in Patients with Pacemakers or Defibrillators: Is It Prime Time Yet? , 2005, Pacing and clinical electrophysiology : PACE.

[11]  E. Martin,et al.  Can cardiac pacemakers and magnetic resonance imaging systems co-exist? , 2005, European heart journal.

[12]  D. Pennell,et al.  Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices , 2004, Heart.

[13]  F. Shellock,et al.  MR procedures: biologic effects, safety, and patient care. , 2004, Radiology.

[14]  Frank G Shellock,et al.  Biomedical implants and devices: Assessment of magnetic field interactions with a 3.0‐Tesla MR system , 2002, Journal of magnetic resonance imaging : JMRI.

[15]  Frank G Shellock,et al.  New metallic implant used for permanent contraception in women: evaluation of MR safety. , 2002, AJR. American journal of roentgenology.

[16]  Frank G Shellock,et al.  Magnetic resonance imaging and permanent cosmetics (tattoos): Survey of complications and adverse events , 2002, Journal of magnetic resonance imaging : JMRI.

[17]  B. Condon,et al.  Thermal injuries associated with MRI. , 2001, Clinical radiology.

[18]  N. Hylton Suspension of breast-feeding following gadopentetate dimeglumine administration. , 2000, Radiology.

[19]  F G Shellock,et al.  Prosthetic heart valves: Evaluation of magnetic field interactions, heating, and artifacts at 1.5 T , 2000, Journal of magnetic resonance imaging : JMRI.

[20]  F. Shellock Pocket Guide to MR Procedures and Metallic Objects: Update 2001 , 2000 .

[21]  F. Shellock,et al.  Safety of magnetic resonance imaging contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.

[22]  E Kanal,et al.  Aneurysm clips: effects of long-term and multiple exposures to a 1.5-T MR system. , 1999, Radiology.

[23]  Mark J. Rieumont,et al.  Pocket Guide to MR Procedures and Metallic Objects: Update 1994 , 1995 .

[24]  L. Carter Canadian Radiologists Foster Educational Propaganda , 1931 .

[25]  S. Cowper,et al.  Nephrogenic systemic fibrosis: an overview. , 2008, Journal of the American College of Radiology : JACR.

[26]  F. Shellock,et al.  MR in patients with pacemakers and ICDs: Defining the issues. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[27]  E. Davies,et al.  The radiological features of gastric lymphoma. , 1977, Clinical radiology.